1. Home
  2. LYEL vs PLL Comparison

LYEL vs PLL Comparison

Compare LYEL & PLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYEL
  • PLL
  • Stock Information
  • Founded
  • LYEL 2018
  • PLL 2016
  • Country
  • LYEL United States
  • PLL United States
  • Employees
  • LYEL N/A
  • PLL N/A
  • Industry
  • LYEL Biotechnology: Pharmaceutical Preparations
  • PLL Other Metals and Minerals
  • Sector
  • LYEL Health Care
  • PLL Basic Materials
  • Exchange
  • LYEL Nasdaq
  • PLL Nasdaq
  • Market Cap
  • LYEL 207.7M
  • PLL 184.1M
  • IPO Year
  • LYEL 2021
  • PLL 2017
  • Fundamental
  • Price
  • LYEL $12.82
  • PLL N/A
  • Analyst Decision
  • LYEL Sell
  • PLL Hold
  • Analyst Count
  • LYEL 2
  • PLL 5
  • Target Price
  • LYEL $15.00
  • PLL $10.31
  • AVG Volume (30 Days)
  • LYEL 24.3K
  • PLL 690.8K
  • Earning Date
  • LYEL 11-06-2025
  • PLL 08-07-2025
  • Dividend Yield
  • LYEL N/A
  • PLL N/A
  • EPS Growth
  • LYEL N/A
  • PLL N/A
  • EPS
  • LYEL N/A
  • PLL N/A
  • Revenue
  • LYEL $60,000.00
  • PLL $105,102,000.00
  • Revenue This Year
  • LYEL N/A
  • PLL N/A
  • Revenue Next Year
  • LYEL N/A
  • PLL $33.37
  • P/E Ratio
  • LYEL N/A
  • PLL N/A
  • Revenue Growth
  • LYEL 11.11
  • PLL 58.18
  • 52 Week Low
  • LYEL $7.65
  • PLL $5.15
  • 52 Week High
  • LYEL $32.00
  • PLL $15.44
  • Technical
  • Relative Strength Index (RSI)
  • LYEL 64.71
  • PLL 14.27
  • Support Level
  • LYEL $12.59
  • PLL $8.48
  • Resistance Level
  • LYEL $13.50
  • PLL $9.43
  • Average True Range (ATR)
  • LYEL 0.67
  • PLL 0.25
  • MACD
  • LYEL 0.18
  • PLL -0.73
  • Stochastic Oscillator
  • LYEL 76.87
  • PLL 0.00

About LYEL Lyell Immunopharma Inc.

Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.

About PLL Piedmont Lithium Inc.

Piedmont Lithium Inc, is a U.S. based, development-stage, multi-asset, integrated lithium business in support of a clean energy economy and U.S. and world-wide energy security. Its portfolio of wholly-owned projects includes Carolina Lithium, a proposed fully integrated spodumene ore-to-lithium hydroxide project in Gaston County, North Carolina, and Tennessee Lithium, a proposed merchant lithium hydroxide manufacturing plant in McMinn County, Tennessee.

Share on Social Networks: